发明名称 Protocol for Risk Stratification of Ischemic Events and Optimized Individualized Treatment
摘要 A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit preparation of an individualized assessment of ischemic event risk and individualized treatment of a subject.
申请公布号 US2011117586(A1) 申请公布日期 2011.05.19
申请号 US201113011677 申请日期 2011.01.21
申请人 CORA HEALTHCARE, INC. 发明人 COHEN ELI
分类号 C12Q1/56;C12M1/34 主分类号 C12Q1/56
代理机构 代理人
主权项
地址